Studies suggest that AOD9604 does not bind the growth hormone receptor and does not activate the JAK2/STAT5 pathway, which accounts for the absence of growth-promoting or IGF-1-elevating effects observed in animal studies
Trypanosoma cruzi: preference for brown adipose tissue in mice by the Tulahuen strain
Supportive Therapies To maximize AOD-9604s metabolic benefits, consider integrating: Structured nutrition protocols: Moderate caloric deficit (15-20% below maintenance), adequate protein intake (0.8-1.2 g/lb body weight) to preserve lean mass, strategic carbohydrate timing around training, and whole-food focused diet to support overall metabolic health
Have sluggish thyroid function but are not candidates for thyroid hormone therapy
Informal reports cannot show whether 5-Amino-1MQ caused a change, and animal timelines should not be converted into human expectations
For those managing a diagnosed deficiency, ongoing treatments may be recommended on a consistent schedule